Documentation Centre

 

 

  of 5698 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation.  Diabetes. 2016 Aug 8. pii: db160240 January 20, 2017 Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation. Diabetes. 2016 Aug 8. pii: db160240 Færch K, Vistisen D, Pacini G, Torekov SS, Johansen NB, Witte DR, Jonsson A, Pedersen O, Hansen T, Lauritzen T, Jørgensen ME, Ahrén B, Holst JJ Key Publications
Changes in overall diet quality and subsequent type 2 diabetes risk: Three U.S. prospective cohorts. Diabetes Care. 2016;39:2011-2018 January 20, 2017 Changes in overall diet quality and subsequent type 2 diabetes risk: Three U.S. prospective cohorts. Diabetes Care. 2016;39:2011-2018 Ley SH, Pan A, Li Y, Manson JE, Willett WC, Sun Q, Hu FB Key Publications
Physical activity/exercise and diabetes: A position statement of the American Diabetes Association. Diabetes Care. 2016;39:2065-2079 January 20, 2017 Physical activity/exercise and diabetes: A position statement of the American Diabetes Association. Diabetes Care. 2016;39:2065-2079 Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, Horton ES, Castorino K, Tate DF Key Publications
PCSK9 inhibitors and diabetes risk: a question worth asking? Eur Heart J. 2016;37:2990-2992 January 19, 2017 PCSK9 inhibitors and diabetes risk: a question worth asking? Eur Heart J. 2016;37:2990-2992 Sattar N Key Publications
Association between long-term exposure to air pollution and biomarkers related to insulin resistance, subclinical inflammation and adipokines. diabetes. 2016 pii: db151567 January 19, 2017 Association between long-term exposure to air pollution and biomarkers related to insulin resistance, subclinical inflammation and adipokines. diabetes. 2016 pii: db151567 Wolf K, Popp A, Schneider A, Breitner S, Hampel R, Rathmann W, Herder C, Roden M, Koenig W, Meisinger C, Peters A; KORA-Study Group Key Publications
2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37:2999-3058 January 19, 2017 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37:2999-3058 Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW et al. Key Publications
Relation of cardiorespiratory fitness to risk of subclinical atherosclerosis in men with cardiometabolic syndrome. Am J Cardiol. 2016;118:1282-1286 January 18, 2017 Relation of cardiorespiratory fitness to risk of subclinical atherosclerosis in men with cardiometabolic syndrome. Am J Cardiol. 2016;118:1282-1286 Jae SY, Franklin BA, Schmidt-Trucksass A, Kim DK, Choi YH, Park JB Key Publications
No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies. Eur Heart J. 2016;37:2981-2989 January 18, 2017 No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies. Eur Heart J. 2016;37:2981-2989 Colhoun HM, Ginsberg HN, Robinson JG, Leiter LA, Müller-Wieland D, Henry RR, Cariou B, Baccara-Dinet MT, Pordy R, Merlet L, Eckel RH Key Publications
WHO's war on sugar. Lancet. 2016;388:1956 January 18, 2017 WHO's war on sugar. Lancet. 2016;388:1956 The Lancet Key Publications
Accelerometer-measured dose-response for physical activity, sedentary time, and mortality in US adults. Am J Clin Nutr. 2016;104:1424-1432 January 17, 2017 Accelerometer-measured dose-response for physical activity, sedentary time, and mortality in US adults. Am J Clin Nutr. 2016;104:1424-1432 Matthews CE, Keadle SK, Troiano RP, Kahle L, Koster A, Brychta R, Van Domelen D, Caserotti P, Chen KY, Harris TB, Berrigan D Key Publications

  of 5698 Next page

Go to page: of